Pfizer Manufacturing Belgium NV
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Rijksweg 12, Puurs-Sint-Amands, 2870, Belgium (BEL)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1000654629 · DUNS 370156507
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-06-22
- NAIDrug Quality Assurance2017-11-16
- VAIDrug Quality Assurance2015-06-30
- NAIDrug Quality Assurance2014-03-18
- VAIDrug Quality Assurance2011-09-23
Drugs this plant is listed as making
11 distinct drugs across 30 products name this site in their FDA label.
- adalimumab-afzbPfizer Laboratories Div Pfizer Inc
- AlprostadilPharmacia & Upjohn Company LLC
- Dalteparin SodiumPfizer Laboratories Div Pfizer Inc
- dinoprostonePharmacia & Upjohn Company LLC
- marstacimab-hncqPfizer Laboratories Div Pfizer Inc
- medroxyprogesterone acetatePharmacia & Upjohn Company LLC
- pegvisomantPharmacia & Upjohn Company LLC
- rituximab-pvvrPfizer Laboratories Div Pfizer Inc
- temsirolimusWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- tranexamic acidPfizer Laboratories Div Pfizer Inc
- trastuzumab-qyypPfizer Laboratories Div Pfizer Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.